Peritonsillar Abscess

Clinical Pathways promote evidence-based, safe, and high-value patient care by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by a methodical review of available evidence and consensus among committee members.

Clinical Pathway:

• Peritonsillar Abscess Clinical Pathway algorithm
• Peritonsillar Abscess Clinical Pathway synopsis (provides care standards employed for this clinical pathway)

Inclusion criteria:

• Inclusion:
  • Patients presenting with concern for peritonsillar abscess

Committee members involved in the development :

• Jennifer Bitner, APRN, FNP-C| Emergency Department | Committee Co-chair
• Laura Neff, MD, MPH | Otolaryngology | Committee Chair
• Christopher Kennedy, MD | Emergency Department | Committee Member
• Mauro Rodriguez, DO | Pediatric Emergency Medicine Fellow | Committee Member

EBP Committee Members:

• Todd Glenski, MD, MSHA, FASA | Anesthesiology, Evidence Based Practice
• Megan Gripka, MT (ASCP) SM | Evidence Based Practice

Publication dates:

• Finalized date: 10/2024
• Next expected revision date: 2027

Concerns with content:
If you have any questions regarding this content or identify a broken link, please email evidencebasedpractice@cmh.edu. 

These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.